Business Description
Gaush Meditech Ltd
ISIN : KYG3902N1051
Description
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.25 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.4 | |||||
Debt-to-EBITDA | -3.5 | |||||
Interest Coverage | 7.03 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.08 | |||||
Beneish M-Score | -2.58 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.5 | |||||
3-Year EBITDA Growth Rate | 28 | |||||
3-Year EPS without NRI Growth Rate | 3.8 | |||||
3-Year FCF Growth Rate | 13.5 | |||||
3-Year Book Growth Rate | 292.8 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30.14 | |||||
9-Day RSI | 33.28 | |||||
14-Day RSI | 36.91 | |||||
6-1 Month Momentum % | -44.64 | |||||
12-1 Month Momentum % | -51.18 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.56 | |||||
Quick Ratio | 1.19 | |||||
Cash Ratio | 0.93 | |||||
Days Inventory | 330.69 | |||||
Days Sales Outstanding | 83.8 | |||||
Days Payable | 92.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward Dividend Yield % | 6.61 | |||||
Shareholder Yield % | 6.67 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 50.91 | |||||
Operating Margin % | 22.85 | |||||
Net Margin % | -44.16 | |||||
FCF Margin % | 18.89 | |||||
ROE % | -19.05 | |||||
ROA % | -10.8 | |||||
ROIC % | 9.75 | |||||
ROC (Joel Greenblatt) % | -87.6 | |||||
ROCE % | -10.93 | |||||
Years of Profitability over Past 10-Year | 2 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 13.57 | |||||
PE Ratio without NRI | 13.82 | |||||
Price-to-Owner-Earnings | 11.63 | |||||
PS Ratio | 3.4 | |||||
PB Ratio | 1.4 | |||||
Price-to-Tangible-Book | 4.78 | |||||
Price-to-Free-Cash-Flow | 18.01 | |||||
Price-to-Operating-Cash-Flow | 14.45 | |||||
EV-to-EBIT | -8.97 | |||||
EV-to-EBITDA | -10.66 | |||||
EV-to-Revenue | 2.94 | |||||
EV-to-FCF | 16.71 | |||||
Price-to-Net-Current-Asset-Value | 9.33 | |||||
Earnings Yield (Greenblatt) % | -11.15 | |||||
FCF Yield % | 5.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Gaush Meditech Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 91.521 | ||
EPS (TTM) (€) | 0 | ||
Beta | 0 | ||
Volatility % | 41.45 | ||
14-Day RSI | 36.91 | ||
14-Day ATR (€) | 0.087431 | ||
20-Day SMA (€) | 2.202 | ||
12-1 Month Momentum % | -51.18 | ||
52-Week Range (€) | 1.9 - 5.6 | ||
Shares Outstanding (Mil) | 147.97 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Gaush Meditech Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Gaush Meditech Ltd Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Gaush Meditech Ltd Frequently Asked Questions
What is Gaush Meditech Ltd(FRA:F7Y)'s stock price today?
When is next earnings date of Gaush Meditech Ltd(FRA:F7Y)?
Does Gaush Meditech Ltd(FRA:F7Y) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |